Clindamycin Phosphate Topical Solution USP, 1%, 60 mL bottle, Manufactured for: Glasshouse Pharma...

FDA Recall #D-0365-2024 — Class III — February 20, 2024

Recall #D-0365-2024 Date: February 20, 2024 Classification: Class III Status: Ongoing

Product Description

Clindamycin Phosphate Topical Solution USP, 1%, 60 mL bottle, Manufactured for: Glasshouse Pharmaceuticals Limited Canada, Mississauga, Ontario, Canada, L5N 6R8, NDC 71428-0003-60

Reason for Recall

Defective Container: Out of specification for weight due to a slow leakage at the 12-month stability timepoint.

Recalling Firm

Contract Pharmaceuticals Limited Canada — Mississauga

Classification

Class III — Not likely to cause adverse health consequences.

Product Type

Drugs

Product Quantity

11,750 bottles

Distribution

Nationwide in the U.S. and Puerto Rico

Code Information

Lot #: 119874; Exp 06/30/2025

Status

Ongoing

Voluntary / Mandated

Voluntary: Firm initiated